CN102391148B — 一种高纯度替加环素的合成方法
Assigned to Nanjing Hairun Pharmaceutical Co Ltd · Expires 2014-01-08 · 12y expired
What this patent protects
本发明涉及抗生素药物替加环素(tigecycline)的制备新方法,以9-氨基米诺环素和N-叔丁基甘氨酸为起始原料,其特征在于:N-叔丁基甘氨酸溶于惰性溶剂中,在酸性接受体和氨基酸缩合剂存在下,与9-氨基米诺环素以氨基酸缩合的路线反应3~10h,冷却至室温。通过酸化、中和、萃取、干燥、浓缩、精制得到替加环素。本发明的制备方法简化了操作,所制得的产品纯度达99.5%以上,单杂控制在0.1%以下,差向异构体控制在0.5%以下;收率高,产品稳定性好,适合工业化生产。
USPTO Abstract
本发明涉及抗生素药物替加环素(tigecycline)的制备新方法,以9-氨基米诺环素和N-叔丁基甘氨酸为起始原料,其特征在于:N-叔丁基甘氨酸溶于惰性溶剂中,在酸性接受体和氨基酸缩合剂存在下,与9-氨基米诺环素以氨基酸缩合的路线反应3~10h,冷却至室温。通过酸化、中和、萃取、干燥、浓缩、精制得到替加环素。本发明的制备方法简化了操作,所制得的产品纯度达99.5%以上,单杂控制在0.1%以下,差向异构体控制在0.5%以下;收率高,产品稳定性好,适合工业化生产。
Drugs covered by this patent
- Tygacil (TIGECYCLINE) · Fresenius Kabi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.